RNAZ Transcode Therapeutics, Inc.

Fundamentals / CIK 0001829635 / USD

Transcode Therapeutics, Inc. reported $44.75M in total assets and a net loss of $145.4M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open RNAZ in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$0$0$0-$32.41MFY 2020 Net Income: -$2.34M2020FY 2021 Net Income: -$6.84M2021FY 2022 Net Income: -$17.56M2022FY 2023 Net Income: -$18.55M2023FY 2024 Net Income: -$16.75M2024FY 2025 Net Income: -$34.66M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $13.42M $9.71M $12.26M $10.23M $2.75M $284K
Total Operating Expenses $27.98M $15.66M $19.42M $18.63M $6.15M $727K
Operating Income -$27.98M -$15.66M -$19.42M -$18.63M -$6.15M -$727K
EBITDA -$27.97M -$15.57M -$19.30M -$18.54M -$6.11M -$727K
Interest Income $79K $684 $5.3K $20K $664 $136
Interest Expense $6.6K $27K $56K $32K $95K $395K
Income Before Tax -$34.44M -$16.75M -- -- -- --
Income Tax Expense $226K $0 $0 $0 $53K $0
Net Income -$34.66M -$16.75M -$18.55M -$17.56M -$6.84M -$2.34M
Basic EPS -$52.59 -$1,336.63 -$88,050,733.97 -$1,083,621,591,147.68 -$12,471,109,020,068.87 -$7,852,179,753,376.69
Diluted EPS -$52.59 -$1,336.63 -$88,050,733.97 -$1,083,621,591,147.68 -$12,471,109,020,068.87 -$7,852,179,753,376.69
Basic Shares Outstanding 689.7K 12.6K 0 0 0 0
Diluted Shares Outstanding 689.7K 12.6K 0 0 0 0

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $3.55M $3.69M $5.11M $5.48M $3.16M $2.57M $2.22M $3.64M
Total Operating Expenses $109.7M $6.79M $17.76M $16.03M $4.56M $4.22M $3.17M $5.09M
Operating Income -$109.7M -$6.79M -$17.76M -$16.03M -$4.56M -$4.22M -$3.17M -$5.09M
EBITDA -$109.7M -$6.77M -$17.73M -$16.04M -$4.56M -$4.21M -$3.16M -$5.08M
Interest Income $43K $52K $92K $79K $147 $148 $146 $159
Interest Expense $7.0K -- -- $542 $6.0K $0 $114 $1.8K
Income Before Tax -$107.7M -$6.75M -$17.55M -$13.22M -$4.86M -$4.28M -$12.09M --
Income Tax Expense -- -- -- $226K $0 $0 $0 $0
Net Income -$107.4M -$6.75M -$17.79M -$13.44M -$4.86M -$4.28M -$12.09M -$5.92M
Basic EPS -$9.36 -$7.17 -$21.28 -- -$5.82 -$5.13 -$70.16 --
Diluted EPS -$9.36 -$7.17 -$21.28 -- -$5.82 -$5.13 -$70.16 --
Basic Shares Outstanding 11.5M 957.2K 917.0K -- 833.7K 833.7K 172.3K --
Diluted Shares Outstanding 11.5M 957.2K 917.0K -- 833.7K 833.7K 172.3K --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $17.81M $5.81M $2.77M $4.97M $20.83M $828K
Cash & Short-Term Investments $17.81M $5.81M $2.77M $4.97M $20.83M $828K
Total Current Assets $21.98M $7.09M $4.46M $7.38M $22.73M $831K
Property, Plant & Equipment, Net $371K $52K $121K $209K $206K --
Goodwill $25.74M -- -- -- -- --
Intangible Assets $114.3M -- -- -- -- --
Total Non-Current Assets $140.4M $201K $714K $209K $206K $224K
Total Assets $162.4M $7.29M $5.17M $7.59M $22.94M $1.06M
Deferred Revenue (Current) $0 $25K $27K $0 $31K $0
Total Current Liabilities $3.49M $2.77M $3.49M $4.35M $2.53M $405K
Total Non-Current Liabilities $7.02M $6.54M $38K $0 $0 $4.06M
Total Liabilities $10.52M $9.31M $3.53M $4.35M $2.53M $4.46M
Total Debt (incl. Leases) -- $38K $451K -- -- --
Common Stock $92 $4 $2 $2 $1.3K $464
Retained Earnings -$97.86M -$63.20M -$46.42M -$27.87M -$10.31M -$3.46M
Total Stockholders' Equity $10.34M -$2.02M $1.64M $3.24M $20.40M -$3.41M
Total Equity $10.34M -$2.02M $1.64M $3.24M $20.40M -$3.41M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $4.64M $8.38M $12.84M $17.81M $2.84M $7.37M $11.57M $5.81M
Cash & Short-Term Investments $4.64M $8.38M $12.84M $17.81M $2.84M $7.37M $11.57M $5.81M
Total Current Assets $6.70M $10.64M $16.75M $21.98M $4.75M $8.24M $13.04M $7.09M
Property, Plant & Equipment, Net $9.3K $323K $347K $371K $20K $25K $38K $52K
Goodwill $25.74M $25.74M $25.74M $25.74M -- -- -- --
Intangible Assets $12.30M $114.3M $114.3M $114.3M -- -- -- --
Total Non-Current Assets $38.05M $140.4M $140.4M $140.4M $476K $25K $150K $201K
Total Assets $44.75M $151.0M $157.2M $162.4M $5.23M $8.27M $13.19M $7.29M
Deferred Revenue (Current) $0 $64K $85K $0 $0 $0 $0 $25K
Total Current Liabilities $6.98M $5.40M $5.38M $3.49M $2.97M $1.56M $2.51M $2.77M
Total Non-Current Liabilities $5.63M $7.25M $7.27M $7.02M $833K $554K $392K $6.54M
Total Liabilities $12.61M $12.65M $12.64M $10.52M $3.80M $2.12M $2.90M $9.31M
Total Debt (incl. Leases) -- -- -- -- -- -- -- $38K
Common Stock $1.7K $101 $92 $92 $84 $84 $2.3K $4
Retained Earnings -$229.8M -$122.4M -$115.6M -$97.86M -$84.42M -$79.56M -$75.29M -$63.20M
Total Stockholders' Equity $32.14M -$27.69M $1.25M $10.34M $1.43M $6.15M $10.29M -$2.02M
Total Equity $32.14M -$27.69M $1.25M $10.34M $1.43M $6.15M $10.29M -$2.02M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$34.66M -$16.75M -$18.55M -$17.56M -$6.84M -$2.34M
Depreciation & Amortization $13K $91K $123K $99K $42K $0
Stock-Based Compensation $485K $1.70M $1.04M $395K $186K $45K
Operating Cash Flow -$19.52M -$13.34M -$18.07M -$15.76M -$5.27M -$493K
Capital Expenditure -$6.7K -$22K -$36K -$101K -$255K --
Free Cash Flow -$19.52M -$13.36M -$18.11M -$15.86M -$5.52M --
Investing Cash Flow -$4.4K -$22K -$36K -$101K -$252K --
Common Stock Issued $8.85M $16.40M $15.91M $1.30M -- --
Financing Cash Flow $31.52M $16.40M $15.91M $6.0K $25.52M $1.12M
Net Change in Cash $12.00M $3.04M -$2.20M -$15.86M $20.00M $624K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$107.4M -$6.75M -$17.79M -$13.44M -$4.86M -$4.28M -$12.09M -$5.92M
Depreciation & Amortization $22K $24K $24K -$18K $4.8K $13K $13K $10K
Stock-Based Compensation $315K -- -- $62K $134K $132K $158K $169K
Operating Cash Flow -$7.66M -$5.40M -$4.98M -$8.14M -$4.08M -$4.19M -$3.10M -$3.15M
Capital Expenditure -- -- -- -- -- -- -- -$500
Free Cash Flow -- -- -- -- -- -- -- -$3.15M
Investing Cash Flow -- -- -- -- -- -- -- -$500
Common Stock Issued -- -- -- $1 $0 $0 $8.85M $7.08M
Financing Cash Flow -- -- -- $23.12M -$456K $0 $8.85M $7.08M
Net Change in Cash -$3.75M -$4.45M -$4.98M $14.98M -$4.54M -$4.19M $5.76M $3.94M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -335.4% -- -1130.3% -542.0% -33.5% --
Return on Assets (ROA) -21.3% -229.7% -358.7% -231.5% -29.8% -222.1%
Current Ratio 6.29x 2.56x 1.28x 1.70x 8.97x 2.05x
Quick Ratio 5.10x 2.10x 0.79x 1.14x 8.22x 2.05x
Debt to Equity -- -- 0.27x -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -452.3% -- -3225.2% -335.4% -1902.8% -400.1% -247.9% --
Return on Assets (ROA) -324.8% -28.4% -25.7% -21.3% -519.1% -297.6% -193.4% -229.7%
Current Ratio 0.96x 1.97x 3.11x 6.29x 1.60x 5.27x 5.20x 2.56x
Quick Ratio 0.66x 1.55x 2.39x 5.10x 0.96x 4.71x 4.61x 2.10x
Source: SEC EDGAR CompanyFacts (CIK 0001829635) · from March 31, 2020 Data through September 30, 2026 · synced Nov 21, 2026, 05:12 UTC · Open in terminal